|
Zila, Inc. - Company Profile Snapshot
| Company Profile: |
Zila, Inc. |
| Ticker: |
ZILA |
| Exchanges: |
NAS |
| 2008 Sales: |
45,061,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
UNITED STATES |
| Employees: |
367 |
Business Description
Zila, Inc.. The Group's principal activity is that of a specialty pharmaceutical company which focuses on the prevention, detection and treatment of oral diseases, with a primary focus on oral cancer. ViziLite Plus is its lead product for the early detection of oral abnormalities that could lead to cancer. In addition, the Group designs, manufactures and markets a suite of proprietary products sold exclusively and directly to dental professionals for periodontal disease, including the Rota-dent Professional Powered Brush, the Pro-Select Platinum ultrasonic scaler and a portfolio of oral pharmaceutical products for both in-office and home-care use.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
